2-120019139-G-A
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_020909.4(EPB41L5):c.55G>A(p.Glu19Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020909.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152048Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000478 AC: 12AN: 251278 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461710Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 727174 show subpopulations
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152048Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74264 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.55G>A (p.E19K) alteration is located in exon 2 (coding exon 1) of the EPB41L5 gene. This alteration results from a G to A substitution at nucleotide position 55, causing the glutamic acid (E) at amino acid position 19 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at